tirzepatide surpass trials Time spent in glycaemic control with sustained body weight reduction with tirzepatide: A post hoc analysis of the clinical trial programme - Bergman - 2025 - Diabetes, Obesity and Metabolism Tirzepatide: First Approval | Drugs

This effect is primarily achieved through bodyweight reduction in individuals with obesity and prediabetes

Pre-conception Folic Acid and Multivitamin Supplementation for the Primary and Secondary Prevention of Neural Tube Defects and Other Folic Acid-Sensitive Congenital Anomalies

Safe for most users.

Expert Review of Neurotherapeutics11 :627-637

B.AugustoO

As with any supplement in this stage, we would advice ceasing use if any concerns to arise.As far as tested athletes are concerned - BPC is not currently on the WADA banned list under the section naming peptide hormones, growth factors, related substances, and mimetics (as of October 2020)